Factory 99% ACP-105 Powder CAS 899821-23-9 Muscle Buiking ACP-105

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A189
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: ACP-105
• CAS: 899821-23-9
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Muscle Buiking
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	ACP-105
Appearance	White Powder
CAS NO.	899821-23-9
Molecular Formula	C16H19ClN2O
Storage	Keep in a cool, dry, dark location

 

ACP-105 is a potent and selective androgen receptor modulator with demonstrated partial agonistic activity compared to natural androgen.

 

 

1. Scientific Research: ACP-105 is primarily used in scientific research settings to investigate the biology and pharmacology of androgen receptors, including their wild-type and mutant forms.
2. Drug Discovery: It serves as a valuable tool compound in drug discovery programs aimed at developing novel therapeutic agents for androgen-related disorders.
3. Pharmacological Studies: It is also utilized in pharmacological studies to assess the effects on various biological processes and disease models.

1. Selective Androgen Receptor Modulation: ACP-105 selectively modulates androgen receptors, demonstrating high potency and selectivity for both wild-type and specific mutant androgen receptors such as T877A.
2. Partial Agonism: ACP-105 exhibits partial agonistic activity, which allows for fine-tuning of androgenic effects and potential reduction of side effects associated with full agonism.
3. Potential Therapeutic Applications: Based on its selective and potent modulation of androgen receptors, ACP-105 holds promise for the development of therapies targeting androgen-responsive conditions, including muscle wasting diseases, hypogonadism, and prostate cancer, among others. However, its clinical applications are currently limited to research and drug development stages.